Overexpression of Gremlin promotes non-small cell lung cancer progression (Q38833711)

6 September 2017

title

Overexpression of Gremlin promotes non-small cell lung cancer progression (English)

1 reference

6 September 2017

1 reference

Yunhong Yin

1

1 reference

6 September 2017

Yie Yang

2

1 reference

6 September 2017

Liyun Yang

3

1 reference

6 September 2017

Yan Yang

4

1 reference

6 September 2017

Chunyu Li

5

1 reference

6 September 2017

Xiao Liu

6

1 reference

6 September 2017

Yiqing Qu

7

1 reference

6 September 2017

publication date

21 September 2015

1 reference

6 September 2017

1 reference

6 September 2017

volume

37

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

2597-2602

1 reference

6 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

BMP2 response pattern in human lung fibroblasts predicts outcome in lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Targeting the Gremlin-VEGFR2 axis - a promising strategy for multiple diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

BMP4 and BMP Antagonists Regulate Human White and Beige Adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4093-8

The bone morphogenetic protein antagonist Gremlin is overexpressed in human malignant mesothelioma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26392110

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-015-4093-8

1 reference

Dimensions Publication ID

6 September 2017

1034113814

0 references

1 reference